Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Centers for Disease Control and Prevention
DOI
Abstract
Abstract Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
Description
Citation
Tobolowsky, Farrell A., Fred Nsubuga, Zunera Gilani, et al. 'Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022', Emerging Infectious Diseases, vol. 30/no. 4, (2024), pp. 775-778.